001     864237
005     20210130002456.0
024 7 _ |a 10.1002/ana.25567
|2 doi
024 7 _ |a 0364-5134
|2 ISSN
024 7 _ |a 1531-8249
|2 ISSN
024 7 _ |a altmetric:64563492
|2 altmetric
024 7 _ |a pmid:31376171
|2 pmid
024 7 _ |a WOS:000486000600008
|2 WOS
024 7 _ |a 2128/24823
|2 Handle
037 _ _ |a FZJ-2019-04071
082 _ _ |a 610
100 1 _ |a Dembek, Till A.
|0 0000-0001-7023-146X
|b 0
|e Corresponding author
245 _ _ |a Probabilistic Sweetspots Predict Motor Outcome for DBS in Parkinson's Disease
260 _ _ |a Hoboken, NJ
|c 2019
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1569390300_12885
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a ObjectiveTo investigate whether functional sweet spots of deep brain stimulation (DBS) in the subthalamic nucleus (STN) can predict motor improvement in Parkinson disease (PD) patients.MethodsStimulation effects of 449 DBS settings in 21 PD patients were clinically and quantitatively assessed through standardized monopolar reviews and mapped into standard space. A sweet spot for best motor outcome was determined using voxelwise and nonparametric permutation statistics. Two independent cohorts were used to investigate whether stimulation overlap with the sweet spot could predict acute motor outcome (10 patients, 163 settings) and long‐term overall Unified Parkinson's Disease Rating Scale Part III (UPDRS‐III) improvement (63 patients).ResultsSignificant clusters for suppression of rigidity and akinesia, as well as for overall motor improvement, resided around the dorsolateral border of the STN. Overlap of the volume of tissue activated with the sweet spot for overall motor improvement explained R2 = 37% of the variance in acute motor improvement, more than triple what was explained by overlap with the STN (R2 = 9%) and its sensorimotor subpart (R2 = 10%). In the second independent cohort, sweet spot overlap explained R2 = 20% of the variance in long‐term UPDRS‐III improvement, which was equivalent to the variance explained by overlap with the STN (R2 = 21%) and sensorimotor STN (R2 = 19%).InterpretationThis study is the first to predict clinical improvement of parkinsonian motor symptoms across cohorts based on local DBS effects only. The new approach revealed a distinct sweet spot for STN DBS in PD. Stimulation overlap with the sweet spot can predict short‐ and long‐term motor outcome and may be used to guide DBS programming. ANN NEUROL 2019;86:527–538
536 _ _ |a 572 - (Dys-)function and Plasticity (POF3-572)
|0 G:(DE-HGF)POF3-572
|c POF3-572
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Roediger, Jan
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Horn, Andreas
|0 0000-0002-0695-6025
|b 2
700 1 _ |a Reker, Paul
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Oehrn, Carina
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Dafsari, Haidar S.
|0 0000-0001-8849-4233
|b 5
700 1 _ |a Li, Ningfei
|0 0000-0003-3315-3591
|b 6
700 1 _ |a Kühn, Andrea A.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 8
|u fzj
700 1 _ |a Visser‐Vandewalle, Veerle
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Barbe, Michael T.
|0 P:(DE-Juel1)131613
|b 10
|u fzj
700 1 _ |a Timmermann, Lars
|0 P:(DE-HGF)0
|b 11
773 _ _ |a 10.1002/ana.25567
|g p. ana.25567
|0 PERI:(DE-600)2037912-2
|n 4
|p 527-538
|t Annals of neurology
|v 86
|y 2019
|x 1531-8249
856 4 _ |y Restricted
|u https://juser.fz-juelich.de/record/864237/files/Dembek_et_al-2019-Annals_of_Neurology.pdf
856 4 _ |y Restricted
|x pdfa
|u https://juser.fz-juelich.de/record/864237/files/Dembek_et_al-2019-Annals_of_Neurology.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/864237/files/ana.25567.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/864237/files/ana.25567.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:864237
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131720
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)131613
913 1 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-572
|2 G:(DE-HGF)POF3-500
|v (Dys-)function and Plasticity
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ANN NEUROL : 2017
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ANN NEUROL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21